DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs-Reference-Cited by-同舟云学术

DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs

Published:2013-11-25 Issue:11 Volume:8 Page:e81489
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Xing-Jie,Lu Li-He,Wang Rui-Rui,Wang Yue-Ping,Luo Rong-Hua,Cong Lai Christopher,Yang Liu-Meng,He Yan-Ping,Zheng Yong-Tang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. World AIDS Day Report: Results,2012

2. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV;E De Clercq;Int J Antimicrob Agents,2009

3. Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments;L Menéndez-Arias;Antiviral Res,2013

4. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase;JS Ren;Virus Res,2008

5. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009);MP de Béthune;Antiviral Res,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Synthesis of New 5-Phenyl-2-[(E)-Styryl]-1H-Pyrimidin-6-One Derivatives and Their Inhibitory Activity Toward SARS-CoV-2 Major (MPRO) and Papain-Like Proteases (PLPRO);Pharmaceutical Chemistry Journal;2023-11

2. Synthesis and anti‐HIV activity of non‐nucleoside reverse‐transcriptase inhibitor DB02 phosphate derivatives based on water‐soluble optimization;Drug Development Research;2023-02-08

3. Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection;Viruses;2022-10-28

4. Recent Development of MOF-Based Photothermal Agent for Tumor Ablation;Frontiers in Chemistry;2022-03-16

5. C6-structural optimizations of 2-aryl-1H-pyrazole-S-DABOs: From anti-HIV to anti-DENV activity;Bioorganic Chemistry;2022-02